Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chambost, Hervé"'
Autor:
Mathias, Mary, Abraham, Aby, Belletrutti, Mark, Carcao, Manuel, Carvalho, Manuela, Chambost, Hervé, Chan, Anthony, Dubey, Leonid, Ducore, Jonathan, Gattens, Michael, Gresele, Paolo, Gruel, Yves, Guillet, Benoit, Jiménez-Yuste, Victor, Kitanovski, Lidija, Klukowska, Anna, Lohade, Sunil, Mancuso, Maria Elisa, Oldenburg, Johannes, Pollio, Berardino, Sigaud, Marianne, Vilchevska, Kateryna, Wu, John, Jansen, Martina, Belyanskaya, Larisa, Walter, Olaf, Knaub, Sigurd, Neufeld, Ellis
Publikováno v:
European Journal of Haematology
European Journal of Haematology, 2023, ⟨10.1111/ejh.14040⟩
European Journal of Haematology, 2023, ⟨10.1111/ejh.14040⟩
Introduction: Simoctocog alfa (Nuwiq®) is a 4th generation recombinant FVIII with proven efficacy for the prevention and treatment of bleeding episodes (BEs) in previously treated patients with severe haemophilia A. The NuProtect study assessed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::427bfebdcf4559e4b51cdc4bcc8faee0
https://univ-rennes.hal.science/hal-04165547
https://univ-rennes.hal.science/hal-04165547
Autor:
Itzhar‐baïkian, Nathalie, Borel‐derlon, Annie, Goudemand, Jenny, Bridey, Françoise, Claeyssens, Segolene, Itzhar-Baikian, Nathalie, Harroche, Annie, Desprez, Dominique, Negrier, Claude, Chamouni, Pierre, Chambost, Hervé, Henriet, Céline, Susen, Sophie
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, 2020, 18 (8), pp.1922-1933. ⟨10.1111/jth.14928⟩
Journal of Thrombosis and Haemostasis, Wiley, 2020, 18 (8), pp.1922-1933. ⟨10.1111/jth.14928⟩
Journal of Thrombosis and Haemostasis, 2020, 18 (8), pp.1922-1933. ⟨10.1111/jth.14928⟩
Journal of Thrombosis and Haemostasis, Wiley, 2020, 18 (8), pp.1922-1933. ⟨10.1111/jth.14928⟩
International audience; Background A triple-secured plasma-derived von Willebrand factor (pdVWF) almost devoid of factor VIII (FVIII):WILFACTIN(R), was approved in France in 2003, and then in other countries for the treatment of patients with von Wil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::833242647a511d892454f1cb1d575710
https://hal.inrae.fr/hal-03143538/document
https://hal.inrae.fr/hal-03143538/document
Autor:
Andersson, Nadine G, Chalmers, Elizabeth A, Kenet, Gili, Ljung, Rolf, Makipernaa, Anne, Chambost, Hervé, PedNet Haemophilia Research Foundation
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2019, 104 (10), pp.2100-2106. ⟨10.3324/haematol.2018.209619⟩
Haematologica, 2019, 104 (10), pp.2100-2106. ⟨10.3324/haematol.2018.209619⟩
Haematologica, Ferrata Storti Foundation, 2019, 104 (10), pp.2100-2106. ⟨10.3324/haematol.2018.209619⟩
Haematologica, 2019, 104 (10), pp.2100-2106. ⟨10.3324/haematol.2018.209619⟩
The optimal mode of delivery for a pregnant hemophilia carrier is still a matter of debate. The aim of the study was to determine the incidence of intracranial hemorrhage and other major bleeds in neonates with moderate and severe hemophilia in relat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf2f95032b07aa944da3f0b2ad1e6ad
https://hal-amu.archives-ouvertes.fr/hal-02651928
https://hal-amu.archives-ouvertes.fr/hal-02651928
Autor:
Calvez, Thierry, Chambost, Hervé, Claeyssens-Donadel, Ségolène, d'Oiron, Roseline, Goulet, Véronique, Guillet, Benoît, Héritier, Virginie, Milien, Vanessa, Rothschild, Chantal, Roussel-Robert, Valérie, Vinciguerra, Christine, Goudemand, Jenny, Pan-Petesch, Brigitte
Publikováno v:
Blood
Blood, American Society of Hematology, 2014, 124 (23), pp.3398-408. ⟨10.1182/blood-2014-07-586347⟩
Blood, 2014, 124 (23), pp.3398-408. ⟨10.1182/blood-2014-07-586347⟩
Blood, American Society of Hematology, 2014, 124 (23), pp.3398-408. ⟨10.1182/blood-2014-07-586347⟩
Blood, 2014, 124 (23), pp.3398-408. ⟨10.1182/blood-2014-07-586347⟩
International audience; Six recombinant factor VIII (rFVIII) products have been marketed worldwide. In 2013, the Research of Determinants of Inhibitor Development (RODIN) study group reported an unexpectedly high risk of inhibitor development with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e49a7ef57a45ad13e80b4b1d7de15d46
https://hal.univ-brest.fr/hal-01256069
https://hal.univ-brest.fr/hal-01256069